ChIP Antibodies
Chromatin Immunoprecipitation (ChIP) is the foundational technique for mapping epigenetic landscapes and deciphering complex transcriptional regulatory networks. However, the integrity of any ChIP data—whether for targeted qPCR or genome-wide ChIP-seq—is entirely dependent on the specificity and affinity of the capturing antibody. Pronewbio provides a specialized, highly validated portfolio of ChIP-grade antibodies designed to capture native protein-DNA interactions with absolute precision. Engineered for advanced research in oncology, neurobiology, and developmental biology, our reagents deliver the high signal-to-noise ratios required for reproducible, publication-quality sequencing data.
Target Categories for Comprehensive Epigenetic Profiling
The dynamic nature of chromatin requires specific tools for different regulatory elements. Our catalog encompasses the major classes of epigenetic targets:
- Histone Modification Antibodies: We offer comprehensive coverage of core histone marks, including methylation, acetylation, and phosphorylation. Our antibodies are strictly validated to differentiate between closely related modifications, such as mono-, di-, and tri-methylation states of Histone H3, ensuring no cross-reactivity compromises your peak calling.
- Transcription Factor Antibodies: Capturing transient or low-abundance transcription factor complexes presents a unique challenge. Pronewbio transcription factor antibodies (including targets like beta-Catenin and NF-kappaB) possess the exceptionally high affinity required to pull down these dynamic complexes, even from demanding sample types or low-input protocols utilizing as few as 1 M to 2 M cells.
- Chromatin Remodelers and Cofactors: To fully understand gene regulation, researchers must map the structural modifiers of the genome. Our antibodies targeting epigenetic readers, writers, and erasers are optimized to recover large, multi-subunit chromatin complexes intact.
The Pronewbio Validation Standard
An antibody validated for Western Blotting is not guaranteed to perform in Chromatin Immunoprecipitation. At Pronewbio, we understand that cross-linking and sonication alter epitope availability. We subject our ChIP portfolio to rigorous, application-specific validation.
- Empirical ChIP Testing: Every antibody in this category is functionally tested in actual ChIP assays using standardized, cross-linked chromatin lysates to verify target enrichment over background IgG controls.
- Exceptional Specificity for Sequencing: Purified via advanced affinity chromatography, our antibodies eliminate non-specific genomic background noise. This high level of purity guarantees that the resulting sequencing reads are true reflections of biological binding sites, reducing wasted sequencing depth.
- Lot-to-Lot Consistency: We employ stringent manufacturing controls to ensure identical performance across batches. Your longitudinal studies will remain perfectly comparable, whether you are running a single 1 mL reaction today or a 50 x scale-up experiment next year.
- Broad Compatibility: Our reagents are formulated to integrate seamlessly into diverse workflows. They perform robustly in standard lysis buffers, are highly compatible with both magnetic and agarose bead systems, and have been successfully utilized in advanced protocols such as CUT&RUN and CUT&Tag.
Advancing Translational Research
From defining the altered epigenetic state of patient-derived tumor organoids to mapping neurodevelopmental pathways, reliable target enrichment is critical. Pronewbio ChIP antibodies provide the robust foundation needed to transition from basic discovery to translational applications with absolute confidence in your data.